Article
Epigenetic therapy targeting bone marrow mesenchymal stem cells for age-related bone diseases
16 May 2022
Abstract excerpt
As global aging accelerates, the prevention and treatment of age-related bone diseases are becoming a critical issue. In the process of senescence, bone marrow mesenchymal stem cells (BMSCs) gradually lose the capability of self-renewal and functional differentiation, resulting in impairment of bone tissue regeneration and disorder of bone tissue homeostasis. Alteration in epigenetic modification is an essential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
